“Marvin 2.0 is a robust web-based EDC system already being used in a number of countries for the last five years. We are very pleased to be a part of bringing Marvin 2.0 to Japan. With double data entry capabilities and ease of use, it will also be well accepted by sponsors, investigators and other users involved in clinical trials”, said Takenori Ogawa, President of Asklep Inc.

Quality management in clinical trials is still a great challenge and, hence, the main issue at the 11th DIA Workshop in Tokyo. Tools which allow the creation of high quality data during the overall clinical trial process are more and more significant in getting market approval, today. “That’s why we developed MARVIN, an EDC system which allows an easy, fast, and professional set-up of clinical trials directly through our partner companies. The collaboration with Asklep is a very important step in the direction of a worldwide expansion of MARVIN and our professional services,” said Dr. Lindenau, XClinical’s Head of Business Development. Dr. Lindenau and Olga Steinle, who is part of the business development team, will also be available for discussing the role of the company’s software products regarding quality management, quality assurance, and reliability.

About Asklep

Asklep, Inc., (www.asklep.co.jp) founded in 1992, in Tokyo, Japan, is a full service CRO and part of the INTAGE group of companies. INTAGE, INC., (www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry.

About XClinical

XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.

XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.